top of page

Home
About Us
- Team
- Partners and Collaborators
Pipeline
- CSTI-500
- CSTI-100
The Rare Diseases
- Prader-Willi Syndrome
News
Contact Us
Publications
Blog
More

Use tab to navigate through the menu items.

CSTI-100 / HBS-102

MCHR1 antagonist for the treatment of rare neurological disorders.

CSTI-100 / HBS-102

Phone Number

+1 (518) 275-0176

Email Address

info@consynance.com

Address

Health Sciences Campus

11 University Place

Rensselaer, NY 12144

Sign Up for ConSynance Updates

Get our news and updates on our progress and upcoming events.

Thanks for subscribing!

Quick Links

Home
About Us
Pipeline

Rare Diseases
Partners and Collaborators

© ConSynance Therapeutics | All Rights Reserved 2019

bottom of page